Financial Statements · Financial Reporting
Tabatt Pharmaeconomics OÜ
Official identifier 16021375Record date 14 Mar 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2022
- Period start
- 1 Jan 2022
- Submitted date
- 20 Mar 2024
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 2,062,288 |
| Balance sheet | Cash and cash equivalents | 505,654 |
| Balance sheet | Current assets | 944,730 |
| Balance sheet | Current liabilities | 192,535 |
| Balance sheet | Equity | 1,869,753 |
| Balance sheet | Share capital at nominal value | 10,000 |
| Balance sheet | Non-current assets | 1,117,558 |
| Balance sheet | Retained earnings (loss) from previous periods | 90,195 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -30,708 |
| Income statement scheme 1 | Revenue | 41,100 |
| Income statement scheme 1 | Annual period profit / loss | 601,550 |
| Income statement scheme 1 | Operating profit (loss) | 601,515 |
| Income statement scheme 1 | Profit (loss) before income tax | 601,550 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 90,195 |
| Kasumi jaotamise otsus | Retained earnings (loss) from previous periods | 90,195 |
| Note: Labour costs | Employees | 0 |
| Note: Labour costs | Labour costs | 0 |
Linked company
Company: Tabatt Pharmaeconomics OÜ